Skip to main content
Top
Published in: Current Cardiology Reports 11/2015

01-11-2015 | Hypertension (WB White and AJ Peixoto, Section Editors)

Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies

Author: Samuel J. Mann

Published in: Current Cardiology Reports | Issue 11/2015

Login to get access

Abstract

Although “labile hypertension” is regularly encountered by clinicians, there is a paucity of information available to guide therapeutic decisions. This review discusses its clinical relevance, the limitations of current knowledge, and possible directions for future research and clinical management. Results of studies that assessed measures of blood pressure variability or reactivity are reviewed. The limited information about effects of antihypertensive drugs on blood pressure variability is discussed. Two different clinical presentations are differentiated: labile hypertension and paroxysmal hypertension. Labile hypertension remains a clinical impression without defined criteria or treatment guidance. Paroxysmal hypertension, also called pseudopheochromocytoma, presents as dramatic episodes of abrupt and severe blood pressure elevation. The disorder can be disabling. Although it regularly raises suspicion of a pheochromocytoma, such a tumor is found in <2 % of patients. The cause, which involves both emotional factors and the sympathetic nervous system, and treatment approaches, are presented.
Literature
1.
go back to reference Mann SJ. The clinical spectrum of labile hypertension: a management dilemma. J Clin Hypertens. 2009;11(9):491–7.CrossRef Mann SJ. The clinical spectrum of labile hypertension: a management dilemma. J Clin Hypertens. 2009;11(9):491–7.CrossRef
2.
go back to reference Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011;57(2):160–6.CrossRefPubMed Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011;57(2):160–6.CrossRefPubMed
3.
go back to reference de la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53(3):466–72.CrossRefPubMed de la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53(3):466–72.CrossRefPubMed
4.
go back to reference Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983;53(1):96–104.CrossRefPubMed Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983;53(1):96–104.CrossRefPubMed
5.
go back to reference Mancia G. Blood pressure variability at normal and high blood pressure. Chest. 1983;83(2 Suppl):317–20.CrossRefPubMed Mancia G. Blood pressure variability at normal and high blood pressure. Chest. 1983;83(2 Suppl):317–20.CrossRefPubMed
6.
go back to reference Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000;36(5):901–6.CrossRefPubMed Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000;36(5):901–6.CrossRefPubMed
7.
go back to reference Conway J, Boon N, Vann Jones J, Sleight P. Mechanisms concerned with blood pressure variability throughout the day. Clin Exp Hypertens A. 1985;7(2–3):153–7.PubMed Conway J, Boon N, Vann Jones J, Sleight P. Mechanisms concerned with blood pressure variability throughout the day. Clin Exp Hypertens A. 1985;7(2–3):153–7.PubMed
8.
go back to reference Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW, et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens. 2003;21(12):2251–7.CrossRefPubMed Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW, et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens. 2003;21(12):2251–7.CrossRefPubMed
9.
go back to reference Khattar RS, Swales JD, Banfield A, Dore C, Senior R, Lahiri A. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation. 1999;100(10):1071–6.CrossRefPubMed Khattar RS, Swales JD, Banfield A, Dore C, Senior R, Lahiri A. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation. 1999;100(10):1071–6.CrossRefPubMed
10.
go back to reference Madden JM, O’Flynn AM, Dolan E, Fitzgerald AP, Kearney PM. Short-term blood pressure variability over 24 h and target organ damage in middle-aged men and women. J Hum Hypertens. 2015. Madden JM, O’Flynn AM, Dolan E, Fitzgerald AP, Kearney PM. Short-term blood pressure variability over 24 h and target organ damage in middle-aged men and women. J Hum Hypertens. 2015.
11.••
go back to reference Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375(9718):895–905. This is the most widely cited study supporting the relationship between visit-to-visit blood pressure variability and cardiovascular prognosis.CrossRefPubMed Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375(9718):895–905. This is the most widely cited study supporting the relationship between visit-to-visit blood pressure variability and cardiovascular prognosis.CrossRefPubMed
12.••
go back to reference Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation. 2012;126(5):569–78. This widely cited study concluded that there was no relationship between visit-to-visit blood pressure variability and cardiovascular prognosis.CrossRefPubMed Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation. 2012;126(5):569–78. This widely cited study concluded that there was no relationship between visit-to-visit blood pressure variability and cardiovascular prognosis.CrossRefPubMed
13.•
go back to reference Parati G, Ochoa JE, Lombardi C, Bilo G. Blood pressure variability: assessment, predictive value, and potential as a therapeutic target. Curr Hypertens Rep. 2015;17(4):537. This recent review summarizes findings as to whether visit-to-visit blood pressure variability predicts cardiovascular outcome.CrossRefPubMed Parati G, Ochoa JE, Lombardi C, Bilo G. Blood pressure variability: assessment, predictive value, and potential as a therapeutic target. Curr Hypertens Rep. 2015;17(4):537. This recent review summarizes findings as to whether visit-to-visit blood pressure variability predicts cardiovascular outcome.CrossRefPubMed
14.
go back to reference Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107(10):1401–6.CrossRefPubMed Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107(10):1401–6.CrossRefPubMed
15.
go back to reference Kario K. Prognosis in relation to blood pressure variability: pro side of the argument. Hypertension. 2015;65(6):1163–9.CrossRefPubMed Kario K. Prognosis in relation to blood pressure variability: pro side of the argument. Hypertension. 2015;65(6):1163–9.CrossRefPubMed
16.•
go back to reference Asayama K, Wei F-F, Hara A, Hansen TW, Li Y, Staessen JA. Prognosis in relation to blood pressure variability: con side of the argument. Hypertension. 2015;65(6):1170–9. This recent review examines the relationship between different measures of blood pressure variability and cardiovascular prognosis.CrossRefPubMed Asayama K, Wei F-F, Hara A, Hansen TW, Li Y, Staessen JA. Prognosis in relation to blood pressure variability: con side of the argument. Hypertension. 2015;65(6):1170–9. This recent review examines the relationship between different measures of blood pressure variability and cardiovascular prognosis.CrossRefPubMed
17.
go back to reference Levy J, Mann SJ, Gerber LM. Non-adherence to recommendations for blood pressure measurement technique in the physician’s office and at home. J Am Soc Hypertens. 2014; e57. Levy J, Mann SJ, Gerber LM. Non-adherence to recommendations for blood pressure measurement technique in the physician’s office and at home. J Am Soc Hypertens. 2014; e57.
18.
go back to reference McKay DW, Campbell NR, Parab LS, Chockalingam A, Fodor JG. Clinical assessment of blood pressure. J Hum Hypertens. 1990;4(6):639–45.PubMed McKay DW, Campbell NR, Parab LS, Chockalingam A, Fodor JG. Clinical assessment of blood pressure. J Hum Hypertens. 1990;4(6):639–45.PubMed
19.
go back to reference Leary AC, Donnan PT, MacDonald TM, Murphy MB. The influence of physical activity on the variability of ambulatory blood pressure. Am J Hypertens. 2000;13(10):1067–73.CrossRefPubMed Leary AC, Donnan PT, MacDonald TM, Murphy MB. The influence of physical activity on the variability of ambulatory blood pressure. Am J Hypertens. 2000;13(10):1067–73.CrossRefPubMed
20.
go back to reference Grassi G. Evaluating sympathetic and haemodynamic responses to mental stressors: hankering or achievement? J Hypertens. 1996;14(10):1155–7.CrossRefPubMed Grassi G. Evaluating sympathetic and haemodynamic responses to mental stressors: hankering or achievement? J Hypertens. 1996;14(10):1155–7.CrossRefPubMed
21.
go back to reference Parati G, Pomidossi G, Casadei R, Ravogli A, Groppelli A, Cesana B, et al. Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. J Hypertens. 1988;6:481–8.CrossRefPubMed Parati G, Pomidossi G, Casadei R, Ravogli A, Groppelli A, Cesana B, et al. Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. J Hypertens. 1988;6:481–8.CrossRefPubMed
22.
go back to reference Krantz DS, Manuck SB. Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodologic critique. Psychol Bull. 1984;96:435–64.CrossRefPubMed Krantz DS, Manuck SB. Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodologic critique. Psychol Bull. 1984;96:435–64.CrossRefPubMed
23.
go back to reference Light KC. Cardiovascular responses to effortful active coping: implications for the role of stress in hypertension development. Psychophysiology. 1981;18:216–25.CrossRefPubMed Light KC. Cardiovascular responses to effortful active coping: implications for the role of stress in hypertension development. Psychophysiology. 1981;18:216–25.CrossRefPubMed
24.
go back to reference Fauvel JP, M’Pio I, Quelin P, Rigaud JP, Laville M, Ducher M. Neither perceived job stress nor individual cardiovascular reactivity predict high blood pressure. Hypertension. 2003;42:1112–6.CrossRefPubMed Fauvel JP, M’Pio I, Quelin P, Rigaud JP, Laville M, Ducher M. Neither perceived job stress nor individual cardiovascular reactivity predict high blood pressure. Hypertension. 2003;42:1112–6.CrossRefPubMed
25.
go back to reference Mann SJ. The mind/body link in essential hypertension: time for a new paradigm. Altern Ther Health Med. 2000;6(2):39–45.PubMed Mann SJ. The mind/body link in essential hypertension: time for a new paradigm. Altern Ther Health Med. 2000;6(2):39–45.PubMed
26.
go back to reference Jorgensen RS, Johnson BT, Kolodziej ME, Schreer GE. Elevated blood pressure and personality: a meta-analytic review. Psychol Bull. 1996;120:293–320.CrossRefPubMed Jorgensen RS, Johnson BT, Kolodziej ME, Schreer GE. Elevated blood pressure and personality: a meta-analytic review. Psychol Bull. 1996;120:293–320.CrossRefPubMed
27.
go back to reference Weder AB, Julius S. Behavior, blood pressure variability, and hypertension. Psychosom Med. 1985;47(5):406–14.CrossRefPubMed Weder AB, Julius S. Behavior, blood pressure variability, and hypertension. Psychosom Med. 1985;47(5):406–14.CrossRefPubMed
28.
go back to reference Mann SJ, Pickering TG, Alderman MH, Laragh JH. Assessment of the effects of alpha- and beta-blockade in hypertensive patients who smoke cigarettes. Am J Med. 1989;86(1B):79–81.CrossRefPubMed Mann SJ, Pickering TG, Alderman MH, Laragh JH. Assessment of the effects of alpha- and beta-blockade in hypertensive patients who smoke cigarettes. Am J Med. 1989;86(1B):79–81.CrossRefPubMed
29.
go back to reference Andrén L, Hansson L. Circulatory effects of stress in essential hypertension. Acta Med Scand Suppl. 1981;646:69–72.PubMed Andrén L, Hansson L. Circulatory effects of stress in essential hypertension. Acta Med Scand Suppl. 1981;646:69–72.PubMed
30.
go back to reference Munakata M, Hiraizumi T, Tomiie T, Saito Y, Ichii S, Nunokawa T, et al. Psychobehavioral factors involved in the isolated office hypertension: comparison with stress-induced hypertension. J Hypertens. 1998;16(4):419–22.CrossRefPubMed Munakata M, Hiraizumi T, Tomiie T, Saito Y, Ichii S, Nunokawa T, et al. Psychobehavioral factors involved in the isolated office hypertension: comparison with stress-induced hypertension. J Hypertens. 1998;16(4):419–22.CrossRefPubMed
31.
go back to reference Verdecchia P, Angeli F, Gattobigio R, Borgioni C, Castellani C, Sardone M, et al. The clinical significance of white-coat and masked hypertension. Blood Press Monit. 2007;12(6):387–9.CrossRefPubMed Verdecchia P, Angeli F, Gattobigio R, Borgioni C, Castellani C, Sardone M, et al. The clinical significance of white-coat and masked hypertension. Blood Press Monit. 2007;12(6):387–9.CrossRefPubMed
32.
go back to reference Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45(2):203–8.CrossRefPubMed Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45(2):203–8.CrossRefPubMed
33.
go back to reference Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata G, et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension. 1998;31(1):57–63.CrossRefPubMed Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata G, et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension. 1998;31(1):57–63.CrossRefPubMed
34.
go back to reference Ugajin TMS, Hozawa AMDP, Ohkubo TMDP, Asayama KMD, Kikuya MMDP, Obara TMS, et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med. 2005;165(13):1541–6.CrossRefPubMed Ugajin TMS, Hozawa AMDP, Ohkubo TMDP, Asayama KMD, Kikuya MMDP, Obara TMS, et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med. 2005;165(13):1541–6.CrossRefPubMed
35.
go back to reference Webb AJS, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375(9718):906–15.CrossRefPubMed Webb AJS, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375(9718):906–15.CrossRefPubMed
36.
go back to reference Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9(5):469–80.CrossRefPubMed Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9(5):469–80.CrossRefPubMed
37.•
go back to reference Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens. 2012;30(6):1241–51. This study offers evidence opposing the findings of Asayama, and concludes that visit-to-visit blood pressure variability is not related to cardiovascular outcome.CrossRefPubMed Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens. 2012;30(6):1241–51. This study offers evidence opposing the findings of Asayama, and concludes that visit-to-visit blood pressure variability is not related to cardiovascular outcome.CrossRefPubMed
38.
go back to reference Mills PJ, Dimsdale JE. Cardiovascular reactivity to psychosocial stressors. A review of the effects of beta-blockade. Psychosomatics. 1991;32(2):209–20.CrossRefPubMed Mills PJ, Dimsdale JE. Cardiovascular reactivity to psychosocial stressors. A review of the effects of beta-blockade. Psychosomatics. 1991;32(2):209–20.CrossRefPubMed
39.
go back to reference Maconochie JG, Richards DA, Woodings EP. Modification of pressor responses induced by ‘cold’ [proceedings]. Br J Clin Pharmacol. 1977;4(3):389.CrossRef Maconochie JG, Richards DA, Woodings EP. Modification of pressor responses induced by ‘cold’ [proceedings]. Br J Clin Pharmacol. 1977;4(3):389.CrossRef
40.
go back to reference Dimsdale JE, Mills P, Ziegler M, Leitz K, Nelesen R. Converting enzyme inhibition and blood pressure reactivity to psychological stressors. Hypertension. 1992;20(2):210–3.CrossRefPubMed Dimsdale JE, Mills P, Ziegler M, Leitz K, Nelesen R. Converting enzyme inhibition and blood pressure reactivity to psychological stressors. Hypertension. 1992;20(2):210–3.CrossRefPubMed
41.
go back to reference Shapiro AP. Pressor responses to noxious stimuli in hypertensive patients. Effects of reserpine and chlorothiazide. Circulation. 1962;26:242–50.CrossRefPubMed Shapiro AP. Pressor responses to noxious stimuli in hypertensive patients. Effects of reserpine and chlorothiazide. Circulation. 1962;26:242–50.CrossRefPubMed
42.
go back to reference Niarchos AP, Pickering TG, Morganti A, Laragh JH. Plasma catecholamines and cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive man. Clin Exp Hypertens A. 1982;4(4–5):761–89.PubMed Niarchos AP, Pickering TG, Morganti A, Laragh JH. Plasma catecholamines and cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive man. Clin Exp Hypertens A. 1982;4(4–5):761–89.PubMed
43.
go back to reference Ulrych M. Changes of general haemodynamics during stressful mental arithmetic and non-stressing quiet conversation and modification of the latter by beta-adrenergic blockade. Clin Sci. 1969;36(3):453–61.PubMed Ulrych M. Changes of general haemodynamics during stressful mental arithmetic and non-stressing quiet conversation and modification of the latter by beta-adrenergic blockade. Clin Sci. 1969;36(3):453–61.PubMed
44.
go back to reference Andrén L, Hansson L, Eggertsen R, Hedner T, Karlberg BE. Circulatory effects of noise. Acta Med Scand. 1983;213(1):31–5.CrossRefPubMed Andrén L, Hansson L, Eggertsen R, Hedner T, Karlberg BE. Circulatory effects of noise. Acta Med Scand. 1983;213(1):31–5.CrossRefPubMed
45.
go back to reference Julius S. The blood pressure seeking properties of the central nervous system. J Hypertens. 1988;6(3):177–85.CrossRefPubMed Julius S. The blood pressure seeking properties of the central nervous system. J Hypertens. 1988;6(3):177–85.CrossRefPubMed
46.
go back to reference Pandhi P, Sharma PL, Sharma BK, Wahi PL. Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure. Int J Clin Pharmacol Ther Toxicol. 1986;24:249–53.PubMed Pandhi P, Sharma PL, Sharma BK, Wahi PL. Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure. Int J Clin Pharmacol Ther Toxicol. 1986;24:249–53.PubMed
47.
go back to reference Anand MP, Dattani KK, Datey KK. Effect of isometric exercise and mental stress on blood pressure--comparative effects of propranolol and labetalol. Indian Heart J 36(1):4–7 Anand MP, Dattani KK, Datey KK. Effect of isometric exercise and mental stress on blood pressure--comparative effects of propranolol and labetalol. Indian Heart J 36(1):4–7
48.
go back to reference Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet. 1994;26:335–46.CrossRefPubMed Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet. 1994;26:335–46.CrossRefPubMed
49.
51.
go back to reference Mann SJ, Gerber LM. Low-dose alpha/beta blockade in the treatment of essential hypertension. Am J Hypertens. 2001;14(6 Pt 1):553–8.CrossRefPubMed Mann SJ, Gerber LM. Low-dose alpha/beta blockade in the treatment of essential hypertension. Am J Hypertens. 2001;14(6 Pt 1):553–8.CrossRefPubMed
52.
go back to reference Frishman W. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties. Am Heart J. 1979;97:663–70.CrossRefPubMed Frishman W. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties. Am Heart J. 1979;97:663–70.CrossRefPubMed
53.
go back to reference Van Peer A, Snoek E, Woestenborghs V, Van de Velde V, Mannerns G, Meuldermans W, et al. Clinical pharmacokinetics of nebivolol. A review. Drug Investig. 1991;3 Suppl 1:25–30.CrossRef Van Peer A, Snoek E, Woestenborghs V, Van de Velde V, Mannerns G, Meuldermans W, et al. Clinical pharmacokinetics of nebivolol. A review. Drug Investig. 1991;3 Suppl 1:25–30.CrossRef
54.
go back to reference Mann SJ. Severe paroxysmal hypertension (pseudopheochromocytoma)—understanding the cause and treatment. Arch Intern Med. 1999;159(7):670–4.CrossRefPubMed Mann SJ. Severe paroxysmal hypertension (pseudopheochromocytoma)—understanding the cause and treatment. Arch Intern Med. 1999;159(7):670–4.CrossRefPubMed
55.
go back to reference Mann SJ. Severe paroxysmal hypertension: an autonomic syndrome and its relationship to repressed emotions. Psychosomatics. 1996;37:444–50.CrossRefPubMed Mann SJ. Severe paroxysmal hypertension: an autonomic syndrome and its relationship to repressed emotions. Psychosomatics. 1996;37:444–50.CrossRefPubMed
56.
go back to reference Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001;134(4):315–29.CrossRefPubMed Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001;134(4):315–29.CrossRefPubMed
57.
go back to reference Sharabi Y, Goldstein DS, Bentho O, Saleem A, Pechnik S, Geraci MF, et al. Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. J Hypertens. 2007;25(11):2286–95.CrossRefPubMed Sharabi Y, Goldstein DS, Bentho O, Saleem A, Pechnik S, Geraci MF, et al. Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. J Hypertens. 2007;25(11):2286–95.CrossRefPubMed
58.
go back to reference Mann SJ. Severe paroxysmal hypertension (pseudopheochromocytoma). Curr Hypertens Rep. 2008;10:12–8.CrossRefPubMed Mann SJ. Severe paroxysmal hypertension (pseudopheochromocytoma). Curr Hypertens Rep. 2008;10:12–8.CrossRefPubMed
Metadata
Title
Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies
Author
Samuel J. Mann
Publication date
01-11-2015
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 11/2015
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-015-0646-0

Other articles of this Issue 11/2015

Current Cardiology Reports 11/2015 Go to the issue

Diabetes and Cardiovascular Disease (S Malik, Section Editor)

EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes